Ikena Oncology
IKNA
$1.69
Share price
0.60%
Change (1 day)
-73.55%
Change (1 year)
Categories
P/S ratio for Ikena Oncology (IKNA)
P/S ratio as of June 2024 (TTM): 21.1
According to Ikena Oncology's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 21.069. At the end of 2023 the company had a P/S ratio of 10.4.
P/S ratio history for Ikena Oncology from 2021 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 10.4 | 49.62% |
| 2022 | 6.94 | -57.62% |
| 2021 | 16.4 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |